These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16050930)

  • 1. Olanzapine-induced gynecomastia.
    Mendhekar DN; Srilakshmi P
    Aust N Z J Psychiatry; 2005 Aug; 39(8):736. PubMed ID: 16050930
    [No Abstract]   [Full Text] [Related]  

  • 2. Delusional misidentification in association with parkinsonism.
    Roane DM; Rogers JD; Robinson JH; Feinberg TE
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):194-8. PubMed ID: 9608408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capgras syndrome in the modern era: self misidentification on an ID picture.
    Grignon S; Trottier M
    Can J Psychiatry; 2005 Jan; 50(1):74-5. PubMed ID: 15756733
    [No Abstract]   [Full Text] [Related]  

  • 4. Capgras syndrome associated with Fahr's disease.
    Mishra BR; Prakash R; Mishra BN; Praharaj SK; Sinha VK
    J Neuropsychiatry Clin Neurosci; 2009; 21(3):354-5. PubMed ID: 19776329
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine-associated bilateral eyelid edema.
    Zink M; Kuwilsky A; Knopf U
    J Clin Psychopharmacol; 2007 Apr; 27(2):214-5. PubMed ID: 17414232
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Myxoedema madness' with Capgras syndrome and catatonic features responsive to combination olanzapine and levothyroxine.
    Shlykov MA; Rath S; Badger A; Winder GS
    BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27613262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated nocturnal auditory hallucinations: a case report.
    Mishra BR; Sarkar S; Mishra S; Mishra A; Praharaj SK; Nizamie SH
    Gen Hosp Psychiatry; 2011; 33(5):530.e5-6. PubMed ID: 21749838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive citalopram is effective on hallucinations and depersonalization symptoms: a case report.
    Di Michele V; Bolino F
    Eur Psychiatry; 2004 May; 19(3):185. PubMed ID: 15158931
    [No Abstract]   [Full Text] [Related]  

  • 9. Capgras delusion with violent behavior in Alzheimer dementia: case analysis with literature review.
    Kaufman KR; Newman NB; Dawood A
    Ann Clin Psychiatry; 2014 Aug; 26(3):187-91. PubMed ID: 24812655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine in the treatment of resistant depression.
    Caetano D; Caetano SC
    Aust N Z J Psychiatry; 2005; 39(1-2):108-9. PubMed ID: 15660713
    [No Abstract]   [Full Text] [Related]  

  • 11. Lilliputian hallucinations in schizophrenia: a case report.
    Grover S; Kattharaghatta Girigowda V; Kumar V
    Afr J Psychiatry (Johannesbg); 2012 Sep; 15(5):311, 313. PubMed ID: 23044883
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of head drop after discontinuation of olanzapine in a DLB patient.
    Aries MJ; Debruyne H; Engelborghs S; Le Bastard N; Somers N; Gorissen D; Pickut BA; De Deyn PP
    Mov Disord; 2008 Sep; 23(12):1760-2. PubMed ID: 18661562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin syndrome caused by olanzapine and clomipramine.
    Margetić B; Aukst-Margetić B
    Minerva Anestesiol; 2008; 74(7-8):445; author reply 446-7. PubMed ID: 18612270
    [No Abstract]   [Full Text] [Related]  

  • 14. Depression, attempted suicide, and suicide in patients with chronic schizophrenia.
    Roy A
    Psychiatr Clin North Am; 1986 Mar; 9(1):193-206. PubMed ID: 2421271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 16. Olanzapine plus venlafaxine in treatment-resistant depression.
    Devarajan S; Dursun SM
    J Psychopharmacol; 2005 Jul; 19(4):434-5. PubMed ID: 15983004
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine usage associated with neuroleptic malignant syndrome.
    Philibert RA; Adam LA; Frank FM; Carney-Doebbeling C
    Psychosomatics; 2001; 42(6):528-9. PubMed ID: 11815691
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.
    De Deyn PP; Carrasco MM; Deberdt W; Jeandel C; Hay DP; Feldman PD; Young CA; Lehman DL; Breier A
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):115-26. PubMed ID: 14758577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delirium with visual hallucinations induced by low-dose olanzapine.
    Takeuchi N; Makino T; Nishihara M
    Psychogeriatrics; 2022 May; 22(3):415-416. PubMed ID: 35274396
    [No Abstract]   [Full Text] [Related]  

  • 20. A Case of Chronic Peduncular Hallucinosis in a 90-Year-Old Woman Successfully Treated With Olanzapine.
    Pascal de Raykeer R; Hoertel N; Manetti A; Rene M; Blumenstock Y; Schuster JP; Limosin F
    J Clin Psychopharmacol; 2016 Jun; 36(3):285-6. PubMed ID: 27043125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.